Natural triterpenic fungicide compound from plant epicuticular waxes
A natural-origin triterpenic compound, particularly isoarborinol derivatives, isolated from evergreen plant epicuticular waxes with demonstrated antifungal properties. Offers a bio-based alternative for plant disease management, leveraging plants' natural defense mechanisms for crop protection.
Overview
This solution centers on a natural-origin triterpenic compound, with particular emphasis on isoarborinol derivatives, extracted from the epicuticular waxes of evergreen plants. These compounds are naturally produced by plants to provide antifungal protection to organs covered by snow during cold seasons. While isoarborinol derivatives have documented antifungal activity, they have not yet been applied in commercial plant health management. This represents an untapped opportunity to develop bio-based fungicides from a renewable, plant-derived source.
The value proposition lies in translating a naturally occurring defense mechanism into a practical agricultural input. By harnessing compounds that plants themselves produce to resist fungal pathogens, this approach offers a potentially sustainable alternative to synthetic fungicides, aligning with growing demand for natural crop protection solutions.
Technical specifications
Key features:
- Active compound: Triterpenic fraction containing isoarborinol derivatives as the primary bioactive constituents
- Source: Epicuticular waxes of evergreen plants that survive winter conditions under snow cover
- Mechanism: Antifungal activity derived from the plant's own protective chemistry
- Form: Isolated triterpenic fraction and individual purified compounds
- Validation status: Compounds have been isolated and identified; antifungal activity is established in existing literature
The research approach focuses on isolating and characterizing these compounds from plant waxes, where they naturally accumulate as part of the plant's defense system against fungal pathogens during vulnerable winter months.
Technology readiness level
The technology is currently at an early research stage. The triterpenic fraction and individual isoarborinol compounds have been successfully isolated from plant epicuticular waxes. The antifungal properties of these compounds are supported by published scientific evidence. However, application-specific validation in plant health management formulations, field efficacy testing, and commercial-scale extraction processes have not yet been performed. Further research is needed to develop practical fungicide formulations and demonstrate effectiveness in agricultural settings.
About Lithuanian University of Health Sciences
Lithuanian University of Health Sciences is a comprehensive public institution focused on human and animal health, combining education, research, and care across an integrated campus in Kaunas. Integration with university-owned hospitals and a veterinary teaching hospital gives industry partners direct access to clinical environments and regulated studies. Co-located core laboratories, simulation and training facilities, and coordinated clinical research support streamline feasibility, recruitment, and data capture, while proximity to a regional medtech and biopharma cluster enables agile collaboration. Research is backed by competitive funding from European Commission programs (e.g., Horizon Europe), European structural funds, and the Research Council of Lithuania. A dedicated technology transfer office advances IP, licensing, and startup creation.
delivered to your inbox.